We are live on
!
Find out more
ECP
Elk Creek Partners Portfolio holdings
AUM
$582M
1-Year Est. Return
10.23%
This Fund
S&P 500
This Quarter
Est. Return
+2.84%
1 Year Est. Return
-10.23%
3 Year Est. Return
+16.39%
5 Year Est. Return
+41.52%
10 Year Est. Return
–
AUM
$1.71B
AUM Growth
+$11.8M
(+0.7%)
Cap. Flow
+$9.72M
Cap. Flow
% of AUM
0.57%
Top 10 Holdings %
Top 10 Hldgs %
21.59%
Holding
168
New
11
Increased
69
Reduced
76
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
+$21M |
| 2 |
EXAS
Exact Sciences
EXAS
|
+$18.8M |
| 3 |
IPHI
INPHI CORPORATION
IPHI
|
+$13.7M |
| 4 |
Pacira BioSciences
PCRX
|
+$12.2M |
| 5 |
FMI
Foundation Medicine, Inc.
FMI
|
+$10M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HAWK
Blackhawk Network Holdings, Inc. Common Stock
HAWK
|
+$29.7M |
| 2 |
Sarepta Therapeutics
SRPT
|
+$25.2M |
| 3 |
CALD
Callidus Software, Inc.
CALD
|
+$20.9M |
| 4 |
EFOR
Everforth Inc
EFOR
|
+$18.4M |
| 5 |
Chegg
CHGG
|
+$15.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.35% |
| 2 | Industrials | 20% |
| 3 | Technology | 17.18% |
| 4 | Consumer Discretionary | 10.86% |
| 5 | Communication Services | 9.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZAYO
126
DELISTED
Zayo Group Holdings, Inc.
ZAYO
| $3.97M | 0.23% |
116,106
-990
| -0.8% | -$35.7K |
|
127
Gartner
IT
$10.1B
| $3.96M | 0.23% |
33,690
-10,451
| -24% | -$1.31M |
|
128
AGCO
AGCO
$7.15B
| $3.8M | 0.22% |
58,589
-473
| -0.8% | -$32.7K |
|
129
SBA Communications
SBAC
$19.2B
| $1.3M | 0.08% |
7,599
+1,110
| +17% | +$184K |
|
130
Centene
CNC
$30.7B
| $795K | 0.05% |
14,886
+2,500
| +20% | +$130K |
|
131
Vertex Pharmaceuticals
VRTX
$121B
| $647K | 0.04% |
3,972
+580
| +17% | +$94.7K |
|
132
Skyworks Solutions
SWKS
$9.37B
| $587K | 0.03% |
5,850
+854
| +17% | +$88.8K |
|
133
MGM Resorts International
MGM
$11.4B
| $545K | 0.03% |
15,568
+2,274
| +17% | +$79.9K |
|
134
SiriusXM
SIRI
$9.98B
| $541K | 0.03% |
8,674
+1,267
| +17% | +$76.1K |
|
135
Willis Towers Watson
WTW
$31.2B
| $521K | 0.03% |
3,421
+500
| +17% | +$78.5K |
|
|
ALXN
136
DELISTED
Alexion Pharmaceuticals
ALXN
| $518K | 0.03% |
4,643
+800
| +21% | +$95.6K |
|
137
JB Hunt Transport Services
JBHT
$25.5B
| $477K | 0.03% |
4,074
+904
| +29% | +$108K |
|
138
BioMarin Pharmaceuticals
BMRN
$11.6B
| $453K | 0.03% |
5,591
+817
| +17% | +$70.1K |
|
139
Bread Financial
BFH
$4.37B
| $440K | 0.03% |
2,590
+1,338
| +107% | +$261K |
|
140
Genpact
G
$5.96B
| $440K | 0.03% |
13,761
+2,009
| +17% | +$65.2K |
|
|
WRK
141
DELISTED
WestRock Company
WRK
| $412K | 0.02% |
6,426
+1,387
| +28% | +$91.6K |
|
142
Snap-on
SNA
$21.2B
| $407K | 0.02% |
2,756
+402
| +17% | +$66.1K |
|
143
DaVita
DVA
$15.4B
| $393K | 0.02% |
5,956
+1,305
| +28% | +$95.8K |
|
144
Ametek
AME
$55.4B
| $384K | 0.02% |
5,061
+739
| +17% | +$56.1K |
|
145
IQVIA
IQV
$38.7B
| $381K | 0.02% |
3,885
+868
| +29% | +$87.7K |
|
146
Aramark
ARMK
$15B
| $340K | 0.02% |
11,905
+1,738
| +17% | +$53.3K |
|
|
CXO
147
DELISTED
CONCHO RESOURCES INC.
CXO
| $328K | 0.02% |
2,182
+319
| +17% | +$48.6K |
|
148
CBRE Group
CBRE
$42.5B
| $300K | 0.02% |
6,346
+927
| +17% | +$42.2K |
|
149
Expeditors International
EXPD
$22B
| $278K | 0.02% |
4,391
+641
| +17% | +$41.2K |
|
150
Expedia Group
EXPE
$35.4B
| $274K | 0.02% |
2,486
+363
| +17% | +$42.2K |
|
Similar funds
BAC
AVC
OWD
PP
WWM
JA
PL
EA
Elk Creek Partners's Q1 2018 Portfolio in Review
As of Q1 2018, Elk Creek Partners held 168 positions worth $1.71B, up 0.7% from $1.7B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Elk Creek Partners's Q1 2018 filing shows 11 new, 69 increased, 76 reduced and 12 closed positions. Its largest new stake was Intercept Pharmaceuticals, Inc.: 348,454 shares worth $21.4M. The largest sale was Blackhawk Network Holdings, Inc. Common Stock, an estimated $29.7M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 17% a quarter earlier, followed by Industrials and Technology.
- Elk Creek Partners's largest Q1 2018 buy was Intercept Pharmaceuticals, Inc.: 348,454 shares worth $21.4M.
- Elk Creek Partners added most to Exact Sciences in Q1 2018, an estimated $18.8M increase.
- Elk Creek Partners's biggest Q1 2018 reduction was Sarepta Therapeutics, cutting an estimated $25.2M.
- Elk Creek Partners fully exited Blackhawk Network Holdings, Inc. Common Stock in Q1 2018, selling an estimated $29.7M.
- Elk Creek Partners's ten largest holdings make up 22% of its $1.71B portfolio in Q1 2018.
- Elk Creek Partners opened 11 new positions and closed 12 in Q1 2018.
- Elk Creek Partners's portfolio value rose 0.7% quarter-over-quarter to $1.71B.
Based on Elk Creek Partners's 13F filing for Q1 2018, filed 11 May 2018.